Best for
Mobile
How to buy Adamis Pharmaceuticals shares | $0.8048
Own Adamis Pharmaceuticals shares in just a few minutes. Share price changes are updated daily.
Adamis Pharmaceuticals Corporation (ADMP) is a leading drug manufacturers-specialty & generic business based in the US. It opened the day at $0.7909 after a previous close of $0.78. During the day the price has varied from a low of $0.7602 to a high of $0.8184. The latest price was $0.8048 (25 minute delay). Adamis Pharmaceuticals is listed on the NASDAQ and employs 131 staff. All prices are listed in US Dollars.
How to buy shares in Adamis Pharmaceuticals
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ADMP in this case.
- Research Adamis Pharmaceuticals shares. The platform should provide the latest information available.
- Buy your Adamis Pharmaceuticals shares. It's that simple.
What's in this guide?
- Can I buy shares in Adamis Pharmaceuticals?
- Has coronavirus impacted Adamis Pharmaceuticals shares?
- Adamis Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Adamis Pharmaceuticals stock a buy or sell?
- Adamis Pharmaceuticals performance over time
- Can I short Adamis Pharmaceuticals shares?
- Adamis Pharmaceuticals's financials
- How volatile are Adamis Pharmaceuticals shares?
- Does Adamis Pharmaceuticals pay a dividend?
- Have Adamis Pharmaceuticals shares ever split?
- Other common questions
How has Coronavirus impacted Adamis Pharmaceuticals's share price?
Since the stock market crash in March caused by coronavirus, Adamis Pharmaceuticals's share price has had significant positive movement.
Its last market close was $0.87, which is 27.05% up on its pre-crash value of $0.6347 and 222.22% up on the lowest point reached during the March crash when the shares fell as low as $0.27.
If you had bought $1,000 worth of Adamis Pharmaceuticals shares at the start of February 2020, those shares would have been worth $534.96 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,308.07.
Adamis Pharmaceuticals share price
Use our graph to track the performance of ADMP stocks over time.Adamis Pharmaceuticals shares at a glance
Information last updated 2020-09-29.
| Open | $0.7909 |
|---|---|
| High | $0.8184 |
| Low | $0.7602 |
| Close | $0.8048 |
| Previous close | $0.78 |
| Change | $0.025 |
| Change % | 3.179% |
| Volume | 2,294,385 |
Information last updated 2020-12-27.
| 52-week range | $0.27 - $1.51 |
|---|---|
| 50-day moving average | $0.5141 |
| 200-day moving average | $0.7314 |
| Wall St. target price | $1 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.831 |
Invest in Adamis Pharmaceuticals shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Adamis Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Adamis Pharmaceuticals price performance over time
Historical closes compared with the last close of $0.8048
| 1 week (2021-01-15) | 3.18% |
|---|---|
| 1 month (2020-12-23) | 54.77% |
| 3 months (2020-10-23) | 1.44% |
| 6 months (2020-07-23) | -21.10% |
| 1 year (2020-01-23) | 10.20% |
|---|---|
| 2 years (2019-01-23) | -71.96% |
| 3 years (2018-01-23) | -80.61% |
| 5 years (2016-01-22) | -81.63% |
Adamis Pharmaceuticals financials
| Revenue TTM | $18.4 million |
|---|---|
| Gross profit TTM | $6.3 million |
| Return on assets TTM | -37.61% |
| Return on equity TTM | -102.54% |
| Profit margin | -188.31% |
| Book value | $0.293 |
| Market capitalisation | $48.5 million |
TTM: trailing 12 months
How to short and sell Adamis Pharmaceuticals shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ADMP.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 2.4 million Adamis Pharmaceuticals shares held short by investors – that's known as Adamis Pharmaceuticals's "short interest". This figure is 9.1% down from 2.7 million last month.
There are a few different ways that this level of interest in shorting Adamis Pharmaceuticals shares can be evaluated.
Adamis Pharmaceuticals's "short interest ratio" (SIR)
Adamis Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Adamis Pharmaceuticals shares currently shorted divided by the average quantity of Adamis Pharmaceuticals shares traded daily (recently around 6.1 million). Adamis Pharmaceuticals's SIR currently stands at 0.4. In other words for every 100,000 Adamis Pharmaceuticals shares traded daily on the market, roughly 400 shares are currently held short.
However Adamis Pharmaceuticals's short interest can also be evaluated against the total number of Adamis Pharmaceuticals shares, or, against the total number of tradable Adamis Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adamis Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Adamis Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0261% of the tradable shares (for every 100,000 tradable Adamis Pharmaceuticals shares, roughly 26 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Adamis Pharmaceuticals.
Find out more about how you can short Adamis Pharmaceuticals stock.
Adamis Pharmaceuticals share dividends
We're not expecting Adamis Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have Adamis Pharmaceuticals's shares ever split?
Adamis Pharmaceuticals's shares were split on a 1:17 basis on 13 December 2013. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharmaceuticals shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Adamis Pharmaceuticals shares which in turn could have impacted Adamis Pharmaceuticals's share price.
Adamis Pharmaceuticals share price volatility
Over the last 12 months, Adamis Pharmaceuticals's shares have ranged in value from as little as $0.27 up to $1.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharmaceuticals's is 1.6105. This would suggest that Adamis Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Adamis Pharmaceuticals overview
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California.
Frequently asked questions
More guides on Finder
-
How to buy Adamis Pharmaceuticals shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Adamis Pharmaceuticals shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert